(Q34432555)

English

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy (English)

1 reference

Europe PubMed Central

2 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

serous carcinoma

1 reference

based on heuristic

inferred from title

author name string

Michael G Kelly

1

1 reference

Europe PubMed Central

2 August 2017

David M O'malley

2

1 reference

Europe PubMed Central

2 August 2017

Pei Hui

3

1 reference

Europe PubMed Central

2 August 2017

Jessica McAlpine

4

1 reference

Europe PubMed Central

2 August 2017

Herbert Yu

5

1 reference

Europe PubMed Central

2 August 2017

Thomas J Rutherford

6

1 reference

Europe PubMed Central

2 August 2017

Masoud Azodi

7

1 reference

Europe PubMed Central

2 August 2017

Peter E Schwartz

8

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

2 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

2 August 2017

98

1 reference

Europe PubMed Central

2 August 2017

3

1 reference

Europe PubMed Central

2 August 2017

353-359

1 reference

Europe PubMed Central

2 August 2017

Endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Therapeutic approaches to uterine papillary serous carcinoma: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Uterine papillary serous carcinoma: study of 19 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Optimal management for surgically Stage 1 serous cancer of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.012

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.06.012

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34432555&oldid=1550519028"